UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act
of 1934
Date of Report (Date of earliest event reported): January 23, 2013
THE CLOROX COMPANY
(Exact name of registrant as specified in its
charter)
__________________
| Delaware | 1-07151 | 31-0595760 |
| (State or other jurisdiction of | (Commission File Number) | (I.R.S. Employer |
| incorporation) | Identification No.) |
1221 Broadway, Oakland,
California 94612-1888
(Address of principal
executive offices) (Zip code)
(510) 271-7000
(Registrant's telephone number, including area code)
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective January 23, 2013, the Board of Directors (the “Board”) of The Clorox Company elected Jeffrey Noddle and Rogelio M. Rebolledo to the Board. In addition, the Board appointed Mr. Noddle to the Board’s Management Development & Compensation Committee and appointed Mr. Rebolledo to the Board’s Audit Committee.
A press release announcing the election of Mr. Noddle and Mr. Rebolledo was issued on January 25, 2013, a copy of which is filed as Exhibit 99.1 hereto and is incorporated herein in its entirety.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
| Exhibit | Description | |||
| 99.1 |
Press Release dated January 25, 2013 | |||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| THE CLOROX COMPANY | |||||
| Date: | January 25, 2013 | By: | /s/ Laura Stein | ||
| Senior Vice President – | |||||
| General Counsel | |||||
THE CLOROX COMPANY
FORM 8-K
INDEX TO EXHIBITS
| Exhibit | Description | ||
| 99.1 | Press Release dated January 25, 2013 | ||